Pinnacle Wealth Planning Services Inc. Raises Stake in Synopsys, Inc. $SNPS

Pinnacle Wealth Planning Services Inc. boosted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 12.5% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,222 shares of the semiconductor company’s stock after buying an additional 136 shares during the quarter. Pinnacle Wealth Planning Services Inc.’s holdings in Synopsys were worth $626,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the stock. Nuveen LLC purchased a new stake in shares of Synopsys during the 1st quarter worth approximately $341,480,000. Generation Investment Management LLP bought a new position in Synopsys during the first quarter valued at $240,491,000. Vanguard Group Inc. increased its position in Synopsys by 2.4% in the first quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock worth $6,359,747,000 after buying an additional 346,994 shares during the last quarter. Alliancebernstein L.P. raised its stake in shares of Synopsys by 22.2% in the first quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company’s stock valued at $739,857,000 after buying an additional 313,218 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Synopsys by 20.2% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,816,319 shares of the semiconductor company’s stock valued at $778,928,000 after buying an additional 305,489 shares during the period. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Synopsys Price Performance

Shares of NASDAQ:SNPS opened at $383.82 on Wednesday. The company has a 50 day moving average of $446.18 and a 200 day moving average of $512.51. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52. The stock has a market cap of $71.29 billion, a P/E ratio of 30.13, a P/E/G ratio of 5.02 and a beta of 1.10. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 EPS for the quarter, missing the consensus estimate of $3.75 by ($1.45). The firm had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.77 billion. Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The firm’s revenue for the quarter was up 14.0% on a year-over-year basis. During the same period in the previous year, the business earned $3.43 earnings per share. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. As a group, sell-side analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CFO Shelagh Glaser sold 3,655 shares of Synopsys stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $609.77, for a total transaction of $2,228,709.35. Following the completion of the sale, the chief financial officer owned 15,317 shares in the company, valued at approximately $9,339,847.09. This trade represents a 19.27% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Sassine Ghazi sold 11,366 shares of the company’s stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the completion of the transaction, the chief executive officer owned 71,615 shares in the company, valued at approximately $42,181,951.15. This trade represents a 13.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 30,894 shares of company stock valued at $16,760,783 in the last ninety days. Corporate insiders own 0.62% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. BNP Paribas initiated coverage on Synopsys in a report on Thursday, October 2nd. They issued an “underperform” rating and a $425.00 price objective for the company. Zacks Research upgraded shares of Synopsys from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. The Goldman Sachs Group reduced their target price on shares of Synopsys from $700.00 to $600.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. JPMorgan Chase & Co. dropped their price target on shares of Synopsys from $685.00 to $600.00 and set an “overweight” rating on the stock in a research note on Wednesday, September 10th. Finally, Mizuho cut their price objective on shares of Synopsys from $700.00 to $600.00 and set an “outperform” rating for the company in a report on Thursday, September 11th. Nine analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, Synopsys currently has an average rating of “Hold” and a consensus target price of $562.14.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.